Interferon ?1 (human fibroblast protein moiety)
Optic Neuritis
MidAmerica Neuroscience Research Foundation at Rowe Neurology Instituteprotein_peptidePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Optic Neuritis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fampridine Courtney Casserly | Phase 2/3 | BB |
METHOTREXATE MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | Phase 4 | BB |
Privosegtor Oculis | Phase 3 | B |
SIMVASTATIN Glostrup University Hospital, Copenhagen | Phase 3 | B |
PREDNISONE TABLETS National Eye Institute (NEI) | Phase 3 | B |
View all 15 →
Same molecule, other indications
Interferon ?1 (human fibroblast protein moiety) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →